← Back to Clinical Trials
Recruiting Phase 4 NCT06695208

NCT06695208 Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06695208
Status Recruiting
Phase Phase 4
Sponsor Cairo University
Condition Socket Perservation
Study Type INTERVENTIONAL
Enrollment 11 participants
Start Date 2024-12-01
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Biodentine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.

This trial targets 11 participants in total. It began in 2024-12-01 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

socket preservation using biodentin versus xeno graft for single rooted mandibular teeth

Eligibility Criteria

Inclusion Criteria: * Patients of both sex with badly decayed tooth indicated for extraction * The ages of the patients ranged from 25 to 50 years. * Patients with healthy systemic condition (Medically free) * Adequate inter-arch space for placement of the implant prosthetic part. * Good oral hygiene * Cooperative patients who are willing to commit for 6 months follow up Exclusion Criteria: * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Poor oral hygiene and motivation. * Smokers * Patient with medical condition that contraindicates surgical procedures * Pregnant or nursing. * Substance abuse. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits severe bruxism or clenching. * Active infection or severe inflammation in the area intended for implant placement. * Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Chemo/radio therapy).

Contact & Investigator

Central Contact

maxim gerges, MSc

✉ maxim.gerges@dentistry.cu.edu.eg

📞 +201011466614

Frequently Asked Questions

Who can join the NCT06695208 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 50 Years, studying Socket Perservation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

What phase is the NCT06695208 trial and what does that mean for participants?

Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.

Is NCT06695208 currently recruiting?

Yes, NCT06695208 is actively recruiting participants. Contact the research team at maxim.gerges@dentistry.cu.edu.eg for enrollment information.

Where is the NCT06695208 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT06695208 clinical trial?

NCT06695208 is sponsored by Cairo University. The trial plans to enroll 11 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology